Lipocine Inc. [NASDAQ:LPCN] price is worthing noting Thursday. The current price is $1.56 with a high of $1.57 and $1.39. Analysts see the the current price target is $3.00.
To ground this price against the rest of the market, over the last two 52 weeks, the company is trading -43.68%, while the S&P 500 is trading 0.79%. Traders should note that the company’s next earning date is 11/04/2020. The company has price per sales of 497.56.
The Price is right
Holding a Market Cap of $99.51 million, Lipocine Inc. has seen a trading range over the last year of $0.30-$3.25.
For the last five days, LPCN is up from its last closing price. The average shares trading hands each day is 4.00M.
Using a Force Index Indicator is a good way to look at how strong actual buying and selling pressure is for LPCN. When we apply the Elder Force Index to Lipocine Inc., we are seeing an Elder Force Indicator number of 496039.5.
In the last quarter, LPCN made a profit of 4.22 million. Lipocine Inc. also saw quarter revenue growth year over year of -61.45%.
Looking at popular technical indicators, the company’s 5-day moving average is 1.4240 compared to the 50-day moving average of 4.97%. So, traders might want to tread carefully if they are going to bid.
The Relative Strength Index or RSI is an indicator ranging between 0 and 100 that traders use to determine if a stock is “overbought” or “oversold.” A strong uptrend tending to reach into the “overbought” status is above 70, while a downward trend will stay around the 30 mark. LPCN currently holds a 9-day RSI of 63.96%, while 100-day RSI stands at 52.67%.
Another indicator we believe is worth keeping tabs on is the Moving Average Convergence Divergence or MACD. Similar to the concept of the Force Index — on the basis of price momentum — the MACD gives traders a tool to measure the turning point of a stock even during rapid fluctuations in price. Buy and sell signals are determined by a stock’s relation to the zero line, so if a stock is above a zero line for many weeks it might be a “buy.” On the other hand, if a stock is below the zero line consistently, it might be one to stay away from. Also, if the MACD line reaches a peak and dips, its momentum may be waning. LPCN’s 9-day MACD is 0.0322 and the company’s 100-day MACD stands at 0.0629.
Another area that is important to analyze is insider moves and majority shareholders. While this is not always an error-free way to tell what the future holds for a stock, you can maybe gather important information from reading the tea leaves about who is buying and selling.
The major holders for this stock are 3.68% by insiders and 17.76% by institutions. Regarding institutional holdings, Vanguard Group, Inc. (The) owns 1.68%, while the second top holder, Ameriprise Financial, Inc., currently owns 1.20%.
Over the last six months, insiders have bought 220,000 with the most recent transaction from Higuchi John W., Director, with a purchase at price 0.32 per share.
Overall, the recommended rating for LPCN is Moderate Buy. Currently, the company has 3 analysts watching the stock, and the average quarterly earnings estimate is -0.06.